Organon and AMC to collaborate on RA drug development

Organon, the human health care business of the Dutch Akzo Nobel group, says that it has entered into a research collaboration with fellow Netherlands-based organization, the Academic Medical Center, which will focus on the development of a novel treatment for rheumatoid arthritis.

The company said that it plans to carry out R&D utilizing recently completed work by the AMC which has indicated that therapeutic use of monoclonal antibodies targeting the CD97 antigen may significantly improve the course of the disease. As the institute's Jorg Hamann explained, " CD97 represents a new category of G-protein coupled receptors, which are probably involved in cell migration." Financial terms of the accord were not disclosed.

Agrees collaboration deal with HUYA Biosci